Stock · NSE
SUNPHARMA
1,840.80▲ 0.20 (0.01%)Last 2 days · 15m candles26/5/2026, 20:24:25
Open: 1,841.70High: 1,842.50Low: 1,818.60Prev: 1,840.60
News mentioning SUNPHARMA
VERIFIEDEconomic Times News·1d★ ON YOUR LIST
Margin pressure, slower growth outlook may cap upside for Sun Pharma stockAI summary· NEUTRAL
- ·Sun Pharma reported strong revenue and profit growth in the March quarter.
- ·EBITDA margins faced pressure due to increased investments and lower milestone income.
- ·The company anticipates range-bound margins and moderating revenue growth in FY27.
VERIFIEDET Finance·4d★ ON YOUR LIST
Sun Pharma sees steady FY27 growth, progresses $11.75 bn Organon integration dealAI summary· POSITIVE
- ·Sun Pharma expects high single-digit overall sales growth by FY2027.
- ·The company is progressing with the integration of the $11.75 billion Organon deal.
- ·Organon acquisition completion is targeted for the last quarter of FY2027.
VERIFIEDMint Companies·4d★ ON YOUR LIST
Sun Pharma guides for slower FY27 growth amid regulatory, macro challengesAI summary· NEUTRAL
- ·Sun Pharma expects high single-digit revenue growth for FY27.
- ·The company saw an 11.9% revenue increase in FY26.
- ·Sun Pharma is navigating regulatory challenges and focusing on the obesity-drug market.
Google News, India stocks·4d★ ON YOUR LIST
Sensex today | Stock Market Live, May 22: Sensex drops day's gain, Nifty near 23,700; Max Health, Sun Pharma top losers - BusinessLineVERIFIEDET Markets·4d★ ON YOUR LIST
Sun Pharma Q4 Results: Cons profit rises 26% YoY to Rs 2,714 crore; board approves Rs 5/share dividendAI summary· POSITIVE
- ·Sun Pharma's Q4 profit after tax rose 26% year-on-year to Rs 2,714 crore.
- ·The company's board has approved a dividend of Rs 5 per share.
- ·Profit after tax fell 19% sequentially from Rs 3,369 crore in Q3FY26.
VERIFIEDET Stocks·4d★ ON YOUR LIST
Sun Pharma Q4 Results: Cons profit rises 26% YoY to Rs 2,714 crore; board approves Rs 5/share dividendAI summary· POSITIVE
- ·Sun Pharma's Q4 profit after tax rose 26% year-on-year to Rs 2,714 crore.
- ·The company's board has approved a dividend of Rs 5 per share.
- ·Profit after tax fell 19% sequentially from Rs 3,369 crore in Q3FY26.
VERIFIEDMint Markets·4d★ ON YOUR LIST
Sun Pharma Q4 results 2026: Profit jumps 26% YoY to ₹2,714 crore; recommends final dividend of ₹5 for FY26AI summary· POSITIVE
- ·Sun Pharma reported a 26% year-on-year jump in profit for Q4 FY26, reaching ₹2,714 crore.
- ·The company recommended a final dividend of ₹5 per share for FY26.
- ·The results cover the fourth quarter of the fiscal year 2026.
VERIFIEDET Markets·4d★ ON YOUR LIST
Rahul Shah bullish on pharma, sees Sun Pharma and Aurobindo as key large-cap playsAI summary· POSITIVE
- ·Indian equity markets show a mixed but improving consumption trend.
- ·Page Industries is highlighted as a strong recovery story, while Nykaa and Honasa are viewed cautiously.
- ·The pharma sector continues its outperformance, with Sun Pharma and Aurobindo Pharma looking attractive.
VERIFIEDMint Markets·4d★ ON YOUR LIST
Stocks to watch: Sun Pharma, Hindalco, ITC, Maruti Suzuki among 10 shares in focus today; check list hereAI summary· NEUTRAL
- ·The Sensex declined 135 points, or 0.18%, to finish at 75,183.36 on Thursday.
- ·The Nifty 50 slipped 4 points, or 0.02%, to close at 23,654.70.
- ·Sun Pharma, Hindalco, ITC, and Maruti Suzuki are among 10 shares in focus today.
VERIFIEDET Markets·4d★ ON YOUR LIST
Stocks in news: ITC, LIC, Sun Pharma, Maruti Suzuki, Fino Payments BankAI summary· NEUTRAL
- ·Benchmark indices closed negatively on Thursday amid volatile trade and profit booking.
- ·Analysts expect the Nifty to consolidate within the range of 23,200 to 23,900.
- ·ITC, LIC, Sun Pharma, Maruti Suzuki, and Fino Payments Bank are in focus due to Q4 results and other developments.
VERIFIEDET Stocks·4d★ ON YOUR LIST
Stocks in news: ITC, LIC, Sun Pharma, Maruti Suzuki, Fino Payments BankAI summary· NEUTRAL
- ·Benchmark indices closed negatively on Thursday amid volatile trade and profit booking.
- ·Analysts expect the Nifty to consolidate within the range of 23,200 to 23,900.
- ·ITC, LIC, Sun Pharma, Maruti Suzuki, and Fino Payments Bank are in focus due to Q4 results and other developments.
VERIFIEDET Markets·5d★ ON YOUR LIST
Sun Pharma Q4 Preview: Can Unloxcyt and speciality drugs help pharma major deliver another strong quarter?AI summary· POSITIVE
- ·Sun Pharma is anticipated to achieve double-digit revenue growth in Q4FY26.
- ·Growth drivers include strong performance in speciality drugs, domestic formulations, and emerging markets.
- ·EBITDA growth is expected to be supported by a diversified global business momentum.
VERIFIEDET Stocks·5d★ ON YOUR LIST
Sun Pharma Q4 Preview: Can Unloxcyt and speciality drugs help pharma major deliver another strong quarter?AI summary· POSITIVE
- ·Sun Pharma is anticipated to achieve double-digit revenue growth in Q4FY26.
- ·Growth is expected to be fueled by speciality drugs, domestic formulations, and emerging markets.
- ·EBITDA growth is projected to be supported by a diversified global business momentum.
VERIFIEDET Stocks·6d★ ON YOUR LIST
Sun Pharma Share Price Live Updates: Sun Pharma's Trading MetricsAI summary· NEUTRAL
- ·Sun Pharma's share price is currently being updated live.
- ·The company's trading metrics are the focus of these updates.
- ·No specific trading metrics or price points were provided in the title.
VERIFIEDET Stocks·7d★ ON YOUR LIST
Sun Pharma Share Price Live Updates: Sun Pharma's Current Trading StatusAI summary· NEUTRAL
- ·Sun Pharma's current trading status is being updated live.
- ·The share price of Sun Pharma is the subject of live updates.
- ·Information regarding Sun Pharma's stock is available in real-time.
VERIFIEDET Markets·7d★ ON YOUR LIST
Sun Pharma Share Price Live Updates: Sun Pharma's market performanceAI summary· NEUTRAL
- ·Sun Pharma's share price is currently being updated live.
- ·The company's market performance is the subject of the update.
- ·No further details are available in the provided text.
VERIFIEDMint Markets·8d★ ON YOUR LIST
Vinay Rajani of HDFC Sec suggests Oracle Financial Services, Sun Pharma shares to buyAI summary· NEGATIVE
- ·Indian equity markets saw a significant selloff on May 18.
- ·Sensex and Nifty 50 dropped over 1%.
- ·The BSE Sensex fell over 1,000 points, erasing nearly ₹9 lakh crore in investor wealth.
VERIFIEDET Markets·8d★ ON YOUR LIST
Sun Pharma Share Price Live Updates: Sun Pharma's Recent Trading InsightsAI summary· NEUTRAL
- ·Sun Pharma's share price is currently under live trading updates.
- ·Recent trading insights for Sun Pharma are available.
- ·The company's stock performance is being monitored.
VERIFIEDET Markets·8d★ ON YOUR LIST
Missed Sun Pharma rally? Ajit Mishra say current dip offers fresh entry opportunityAI summary· NEUTRAL
- ·Ajit Mishra suggests the current dip in Sun Pharma presents a fresh entry opportunity.
- ·The title implies a recent rally in Sun Pharma's stock.
- ·The article focuses on potential investment timing for Sun Pharma.
VERIFIEDMint Markets·10d★ ON YOUR LIST
Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday - 18 May 2026AI summary· NEUTRAL
- ·Sun Pharma is approaching a resistance level of 1960 with increasing volumes.
- ·Dabur is showing a bullish trend with potential for gains.
- ·Pidilite Industries is also experiencing a bullish trend and may see further gains.
VERIFIEDET Stocks·11d★ ON YOUR LIST
Sun Pharma Share Price Live Updates: Sun Pharma's Stock Performance This WeekAI summary· NEUTRAL
- ·Sun Pharma's stock performance is being tracked this week.
- ·The title indicates live updates on Sun Pharma's share price.
- ·No specific performance data is available in the provided title.
VERIFIEDET Markets·12d★ ON YOUR LIST
Sun Pharma Share Price Live Updates: Sun Pharma's trading activityAI summary· NEUTRAL
- ·Sun Pharma's trading activity is the subject of live updates.
- ·The company's share price is being monitored.
- ·Information regarding Sun Pharma's stock is currently available.
VERIFIEDET Markets·13d★ ON YOUR LIST
Sun Pharma Share Price Live Updates: Sun Pharma's Monthly Return HighlightsAI summary· NEUTRAL
- ·Sun Pharma's share price is currently being updated live.
- ·The company's monthly returns are a key highlight.
- ·This information is relevant for Indian stock-market traders.
VERIFIEDET Stocks·13d★ ON YOUR LIST
Sun Pharma Share Price Live Updates: Sun Pharma's Monthly Return HighlightsAI summary· NEUTRAL
- ·Sun Pharma's share price is currently being updated live.
- ·The company's monthly returns are a notable highlight.
- ·Further details on the share price performance are available.
VERIFIEDET Markets·14d★ ON YOUR LIST
Sun Pharma Share Price Live Updates: Sun Pharma's beta reflects market stabilityAI summary· NEUTRAL
- ·Sun Pharma's beta reflects market stability.
VERIFIEDET Stocks·15d★ ON YOUR LIST
Sun Pharma Share Price Live Updates: Sun Pharma's Performance in the Last MonthAI summary· NEUTRAL
- ·Sun Pharma's share price performance over the last month is the subject of this update.
- ·The title indicates a focus on live updates regarding Sun Pharma's stock.
- ·No specific financial data or performance metrics are provided in the title.
VERIFIEDET Markets·15d★ ON YOUR LIST
Sun Pharma Share Price Live Updates: Sun Pharma's Performance in the Last MonthAI summary· NEUTRAL
- ·Sun Pharma's share price performance over the last month is the subject of this update.
- ·The title indicates a focus on live updates regarding Sun Pharma's stock.
- ·No specific financial data or performance metrics are provided in the title.